Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

Peart, MJ; Smyth, GK; van Laar, RK; Bowtell, DD; Richon, VM; Marks, PA; Holloway, AJ; Johnstone, RW

Author(s): Peart, MJ; Smyth, GK; van Laar, RK; Bowtell, DD; Richon, VM; Marks, PA; Holloway, AJ; Johnstone, RW;
Details: Publication Year 2005-03-08,Volume 102,Issue #10,Page 3697-3702
Journal Title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publication Type: Journal Article
Abstract: Histone deacetylase inhibitors (HDACis) inhibit tumor cell growth and survival, possibly through their ability to regulate the expression of specific proliferative and/or apoptotic genes. However, the HDACi-regulated genes necessary and/or sufficient for their biological effects remain undefined. We demonstrate that the HDACis suberoylanilide hydroxamic acid (SAHA) and depsipeptide regulate a highly overlapping gene set with at least 22% of genes showing altered expression over a 16-h culture period. SAHA and depsipeptide coordinately regulated the expression of several genes within distinct apoptosis and cell cycle pathways. Multiple genes within the Myc, type beta TGF, cyclin/cyclin-dependent kinase, TNF, Bcl-2, and caspase pathways were regulated in a manner that favored induction of apoptosis and decreased cellular proliferation. APAF-1, a gene central to the intrinsic apoptotic pathway, was induced by SAHA and depsipeptide and shown to be important, but not essential, for HDACi-induced cell death. Overexpression of p16(INK4A) and arrest of cells in G, can suppress HDACi-mediated apoptosis. Although p16(INK4A) did not affect the genome-wide transcription changes mediated by SAHA, a small number of apoptotic genes, including BCLXL and B-MYB, were differentially regulated in a manner consistent with attenuated HDACi-mediated apoptosis in arrested cells. We demonstrate that different HDACi alter transcription of a large and common set of genes that control diverse molecular pathways important for cell survival and proliferation. The ability of HDACi to target multiple apoptotic and cell proliferation pathways may provide a competitive advantage over other chemotherapeutic agents because suppression/loss of a single pathway may not confer resistance to these agents.
Publisher: NATL ACAD SCIENCES
Keywords: CELL-DEATH; LEUKEMIA-CELLS; TGF-BETA; APOPTOSIS; PATHWAYS; EXPRESSION; CANCER; SUPERFAMILY; INDUCTION; FAMILY
Publisher's Version: https://doi.org/10.1073/pnas.0500369102
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2005-03-08 12:00:00